PHAI submits comments to FDA supporting reducing nicotine levels of smoked tobacco products to non-addictive levels

In response to a request for comments, PHAI urges the FDA to prioritize smoked tobacco nicotine reduction as a potentially highly effective tool to mitigate the public health cost of smoking. Please see our complete Comments (pdf).

This entry was posted in Legal Filings, Tobacco and tagged , on by .

About Mark Gottlieb

Mark Gottlieb joined the staff of the Public Health Advocacy Institute in 1993 after graduating from Northeastern University School of Law. His efforts have focused on researching tobacco litigation as a public health strategy as director of the Tobacco Products Liability Project, reducing the harm caused by secondhand tobacco smoke through a variety of legal and policy approaches, fostering scholarship using tobacco industry documents, and, more recently, examining legal and policy approaches to address obesity. He is the Executive Director of the Institute and lives in Cambridge, MA with his wife and three children.